DKSC (Dakshidin) Treasury Stock: $0.00 Mil (As of Sep. 2023)


What is Dakshidin Treasury Stock?

Dakshidin DKSC +33.33% Treasury Stock is $0.00 Mil as of Sep. 2023.

Treasury stock is the portion of shares that a company keeps in their own treasury. Dakshidin's treasury stock for the quarter that ended in Sep. 2023 was $0.00 Mil.

Treasury stock may have come from a repurchase or buyback from shareholders; or it may have never been issued to the public in the first place.

Dakshidin Treasury Stock Historical Data

* Premium members only.

The historical data trend for Dakshidin's Treasury Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Dakshidin Treasury Stock Chart

Dakshidin Annual Data
Trend
Treasury Stock

Dakshidin Quarterly Data
Mar19 Mar20 Sep22 Sep23
Treasury Stock 0.00 0.00 0.00 0.00

Dakshidin Treasury Stock Calculation

The portion of shares that a company keeps in their own treasury. Treasury stock may have come from a repurchase or buyback from shareholders; or it may have never been issued to the public in the first place. These shares don't pay dividends, have no voting rights, and should not be included in shares outstanding calculations.

Frequently Asked Questions Learn more about Treasury Stock →
What does a Treasury Stock of $0.00 Mil mean?
Dakshidin (DKSC) has a Treasury Stock of $0.00 Mil as of Sep. 2023. Treasury stock is a contra-equity item that records the amount of stock not issued to shareholders. View historical data for Dakshidin and its competitors.
Is Dakshidin's Treasury Stock too high?
Dakshidin's current Treasury Stock is $0.00 Mil.
How does Dakshidin's Treasury Stock compare to ECEZ and AFBG?
Dakshidin's Treasury Stock of $0.00 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Treasury Stock for a Drug Manufacturers company?
A good Treasury Stock depends on the Drug Manufacturers industry context. However, Treasury Stock should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Treasury Stock mean?
A high Treasury Stock can signal that a stock is expensive relative to its fundamentals. Treasury stock is a contra-equity item that records the amount of stock not issued to shareholders. View historical data for Dakshidin and its competitors. Dakshidin's current Treasury Stock is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Dakshidin stock overvalued right now?
Dakshidin (DKSC) has a current Treasury Stock of $0.00 Mil. The current Treasury Stock is $0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Treasury Stock calculated?
Treasury Stock is calculated from a company's financial statements. For Dakshidin (DKSC), the current Treasury Stock is $0.00 Mil as of Sep. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Dakshidin Business Description

Address 508 Locust Street, Lockport, NY, USA, 14094
Dakshidin Corp is a Cannabis-based medical product company. The company operates through its online e-commerce store laughingfrogs.com. The company is composed of four synergistic entities: Laughing Frogs, an online sales portal for the company's CBD products; Laughing Frogs Nutraceutical the online sales portal for all non-CBD hemp oil products and its proprietary nutraceutical products, company's new PPE division and Runnymede Farms, a company that is focused on the cultivation of specifically grown Hemp plants. through its growing operations and Joint Ventures with established growers.